Anti-allergy medicine EpiPen recall expands to US

Examples of epinephrine pens that the Center for Disease Control and Prevention guidelines recommend that schools stock to combat food allergies are photographed in the Washington Wednesday, Nov. 13, 2013. (AP Photo/J. David Ake)

NEW YORK (AP) — A recall of the emergency anti-allergy medicine EpiPen is expanding to the U.S. and other markets in North America, Europe, Asia and South America because the allergy shots may not work.

The notice issued Friday by Mylan N.V. expands upon warnings made earlier this month after two reports of the device failing. The recall now covers 13 lots distributed from December 2015 through July 2016.

Mylan didn’t immediately respond to a question about how many devices are affected by the recall.

The problems could be potentially life-threatening, although Mylan described the incidence of the defects as “extremely rare.”

The EpiPen is used to treat allergic reactions to certain food and bug bites

The products can be replaced at no charge by calling 877-650-3494 or emailing customer.service@mylan.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s